Current Fungal Infection Reports

, Volume 4, Issue 4, pp 219–228 | Cite as

Donor-Derived Fungal Infections in Transplant Patients

Article

Abstract

Fungal infection can occur in transplant patients via one of four mechanisms: donor-derived infections, contamination during the transplantation period, reactivation of latent infection in the host, or new infection during the posttransplantation period. Distinguishing between these mechanisms is often difficult and as a result, donor-derived fungal infections may be under-recognized with few data on its prevalence. We review published reports of donor-derived fungal infections and discuss the role of donor screening and the importance of establishing a national reporting, tracking, and notification system for transplant-transmitted infections.

Keywords

Transplantation Infection Fungi Mycoses Tissue and organ procurement Cornea Surveillance Tissue donors Donor selection Adverse events 

References

Papers of particular interest, published recently, have been highlighted as: • Of importance ••Of major importance

  1. 1.
    Chiller TM, Galgiani JN, Stevens DA: Coccidioidomycosis. Infect Dis Clin N Am 2003, 17:41–57.CrossRefGoogle Scholar
  2. 2.
    Blair JE: Approach to the solid organ transplant patient with latent infection and disease caused by Coccidioides species. Curr Opin Infect Dis 2008, 21:415–420.CrossRefPubMedGoogle Scholar
  3. 3.
    Blair JE: Coccidioidomycosis in liver transplantation. Liver Transpl 2006, 12:31–39.CrossRefPubMedGoogle Scholar
  4. 4.
    Blair JE: Coccidioidomycosis in patients who have undergone transplantation. Ann NY Acad Sci 2007, 1111:365–376.CrossRefPubMedGoogle Scholar
  5. 5.
    Braddy CM, Heilman RL, Blair JE: Coccidioidomycosis after renal transplantation in an endemic area. Am J Transpl 2006, 6:340–345.CrossRefGoogle Scholar
  6. 6.
    Calhoun DL, Galgiani JN, Zukoski C, et al.: Coccidioidomycosis in recent renal or cardiac transplant recipients. In Coccidioidomycosis: Proceedings of the 4th International Conference on Coccidioidomycosis, San Diego, 14–17 March 1984. Edited by Einstein HE, Catanzaro A. Washington, DC: National Foundation for Infectious Diseases; 1985:312–318.Google Scholar
  7. 7.
    Cohen MI, Galgiani JN, Potter D, Ogden DA: Coccidioidomycosis in renal replacement therapy. Arch Intern Med 1982, 142:489–494.CrossRefPubMedGoogle Scholar
  8. 8.
    Hall KA, Sethi GK, Rosado LJ, et al.: Coccidioidomycosis and heart transplantation. J Heart Lung Transpl 1993, 12:525–526.Google Scholar
  9. 9.
    Serota AI: The efficacy of fluconazole in prevention of coccidioidomycosis following renal transplantation. In Coccidioidomycosis: Proceedings of the 5th International Conference on Coccidioidomycosis, Stanford University, 24–27 August 1994: Centennial Conference. Edited by Einstein HE, Catanzaro A. Bethesda, MD: National Foundation for Infectious Diseases Press; 1996:248–254.Google Scholar
  10. 10.
    Wright PW, Pappagianis D, Wilson M, et al.: Donor-related coccidioidomycosis in organ transplant recipients. Clin Infect Dis 2003, 37:1265–1269.CrossRefPubMedGoogle Scholar
  11. 11.
    Tripathy U, Yung GL, Kriett, JM, et al.: Donor transfer of pulmonary coccidioidomycosis in lung transplantation. Ann Thorac Surg 2002, 73:306–308.CrossRefPubMedGoogle Scholar
  12. 12.
    Miller MB, Hendren R, Gilligan PH: Posttransplantation disseminated coccidioidomycosis acquired from donor lungs. J Clin Microbiol 2004, 42:2347–2349.CrossRefPubMedGoogle Scholar
  13. 13.
    Carvalho C, Ferreira I, Gaiao S, et al.: Cerebral coccidioidomycosis after renal transplantation in a non-endemic area. Transpl Infect Dis 2010, 12:151–154.CrossRefPubMedGoogle Scholar
  14. 14.
    Blair JE, Mulligan DC: Coccidioidomycosis in healthy persons evaluated for liver or kidney donation. Transpl Infect Dis 2007, 9:78–82.CrossRefPubMedGoogle Scholar
  15. 15.
    Blair JE, Douglas DD, Mulligan DC: Early results of targeted prophylaxis for coccidioidomycosis in patients undergoing orthotopic liver transplantation within an endemic area. Transpl Infect Dis 2003, 5:3–8.PubMedGoogle Scholar
  16. 16.
    • Fischer SA, Avery RK, AST Infectious Disease Community of Practice: Screening of donor and recipient prior to solid organ transplantation. Am J Transplant 2009, 9(Suppl 4):S7–S18. This is a summary of current AST Infectious Disease Community of Practice guidelines for donor and recipient screening prior to solid organ transplantation. CrossRefPubMedGoogle Scholar
  17. 17.
    • Proia L, Miller R, AST Infectious Disease Community of Practice: Endemic fungal infections in solid organ transplant recipients. Am J Transplant 2009, 9(Suppl 4): S199–S207. This article is part of the AST Infectious Disease Community of Practice guidelines and summarizes recommendations on diagnosis, treatment, and pretransplant evaluation of endemic fungal infections in solid organ transplant recipients. CrossRefPubMedGoogle Scholar
  18. 18.
    Wheat LJ: Histoplamosis: a review for clinicians from non-endemic areas. Mycoses 2006, 49:274–282.CrossRefPubMedGoogle Scholar
  19. 19.
    Hood AB, Inglis FG, Lowenstein L, et al.: Histoplasmosis and thrombocytopenic purpura: transmission by renal homotransplantation. Can Med Assoc J 1965, 93:587–592.PubMedGoogle Scholar
  20. 20.
    Sylvestre PB, Gonzalez-Koch AR, Ishitani MB: Histoplasmosis in an explant liver with subsequent seeding of the liver allograft. Liver Transpl 2000, 6:643.CrossRefPubMedGoogle Scholar
  21. 21.
    Limaye AP, Connolly PA, Sagar M, et al.: Transmission of Histoplasma capsulatum by organ transplantation. N Engl J Med 2000, 343:1163–1166.CrossRefPubMedGoogle Scholar
  22. 22.
    Shah SS, Karnak D, Shah SN, et al.: Broncholith caused by donor-acquired histoplasmosis in a lung transplant recipient. J Heart Lung Transplant 2007, 26:407–410.CrossRefPubMedGoogle Scholar
  23. 23.
    Watanabe M, Hotchi M, Nagasaki M: An autopsy case of disseminated histoplasmosis probably due to infection from a renal allograft. Acta Pathol Jpn 1988, 38:769–780.PubMedGoogle Scholar
  24. 24.
    Wong SY, Allen DM: Transmission of disseminated histoplasmosis via cadaveric renal transplant: case report. Clin Infect Dis 1992, 14:232–234.PubMedGoogle Scholar
  25. 25.
    Botterel F, Romand S, Saliba F, et al.: A case of disseminated histoplasmosis likely due to infection from a liver allograft. Eur J Clin Microbiol Infect Dis 1999, 18:662–664.CrossRefPubMedGoogle Scholar
  26. 26.
    Vail GM, Young RS, Wheat LJ, et al.: Incidence of histoplasmosis following allogeneic bone marrow transplant or solid organ transplant in a hyperendemic area. Transpl Infect Dis 2002, 4:148–151.CrossRefPubMedGoogle Scholar
  27. 27.
    Wheat LJ, Smith EJ, Sathapatayavongs B, et al.: Histoplasmosis in renal allograft recipients: two large urban outbreaks. Arch Intern Med 1983, 143:703–707.CrossRefPubMedGoogle Scholar
  28. 28.
    Cuellar-Rodriguez J, Avery RK, Lard M, et al.: Histoplasmosis in solid organ transplant recipients: 10 years of experience at a large transplant center in an endemic area. Clin Infect Dis 2009, 49:710–716.CrossRefPubMedGoogle Scholar
  29. 29.
    Pappas PG, Alexander BD, Andes DR, et al.: Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET). Clin Infect Dis 2010, 50:1101–1111.CrossRefPubMedGoogle Scholar
  30. 30.
    Al-Assiri A, Al-Jastaneiah S, Al-Khalaf A, et al.: Late-onset donor-to-host transmission of Candida glabrata following corneal transplantation. Cornea 2006, 25:123–125.CrossRefPubMedGoogle Scholar
  31. 31.
    Antonios SR, Cameron JA, Badr IA, et al.: Contamination of donor cornea: postpenetrating keratoplasty endophthalmitis. Cornea 1991, 10:217–220.CrossRefPubMedGoogle Scholar
  32. 32.
    Behrens-Baumann W, Ruechel R, Zimmermann O, Vogel M: Candida tropicalis endophthalmitis following penetrating keratoplasty. Br J Opthalmol 1991, 75:565.CrossRefGoogle Scholar
  33. 33.
    Caldwell MC, Perfect JR, Carlson AN, Proia AD: Candida glabrata endophthalmitis following penetrating keratoplasty. J Cataract Refract Surg 2009, 35:598–602.CrossRefPubMedGoogle Scholar
  34. 34.
    Cameron JA, Antonios SR, Cotter JB, Habash NR: Endophthalmitis from contaminated donor corneas following penetrating keratoplasty. Arch Opthalmol 1991, 109:54–59.Google Scholar
  35. 35.
    Chapman FM, Orr KE, Armitage WJ, et al.: Candida glabrata endophthalmitis following penetrating keratoplasty [letter]. Br J Opthalmol 1998, 82:712–713.Google Scholar
  36. 36.
    Fong LP, Gladstone D, Casey TA: Cornea-scleral rim cultures: donor contamination. A case of fungal endophthalmitis transmitted by K-Sol stored cornea. Eye (Lond) 1988, 2:670–676.Google Scholar
  37. 37.
    Insler MS, Urso LF: Candida albicans endophthalmitis after penetrating keratoplasty. Am J Opthalmol 1987, 104:57–60.Google Scholar
  38. 38.
    Keyhani K, Seedor JA, Shah MK, et al.: The incidence of fungal keratitis and endophthalmitis following penetrating keratoplasty. Cornea 2005, 24:288–291.CrossRefPubMedGoogle Scholar
  39. 39.
    Kitzmann AS, Wagoner MD, Syed NA, Goins KM: Donor-related Candida keratitis after Descemet stripping automated endothelial keratoplasty. Cornea 2009, 28:825–828.CrossRefPubMedGoogle Scholar
  40. 40.
    Koenig SB, Wirostko WJ, Fish RI, Covert DJ: Candida keratitis after Descemet stripping and automated endothelial keratoplasty. Cornea 2009, 28:471–473.CrossRefPubMedGoogle Scholar
  41. 41.
    Kloess PM, Stulting RD, Waring GO 3rd, Wilson LA: Bacterial and fungal endophthalmitis after penetrating keratoplasty. Am J Opthalmol 1993, 115:309–316.Google Scholar
  42. 42.
    Larsen PA, Lindstrom RL, Doughman DJ: Torulopsis glabrata endophthalmitis after keratoplasty with an organ-cultured cornea. Arch Opthalmol 1978, 96:1019.Google Scholar
  43. 43.
    Leveille AS, McMullan FD, Cavanagh HD: Endophthalmitis following penetrating keratoplasty. Ophthalmology 1983, 90:38–39.PubMedGoogle Scholar
  44. 44.
    Merchant A, Zacks CM, Wilhelmus K, et al.: Candidal endophthalmitis after keratoplasty. Cornea 2001, 20:226–229.CrossRefPubMedGoogle Scholar
  45. 45.
    Schotveld JH, Raijmakers AJ, Henry Y, Zaal MJ: Donor-to-host transmitted Candida endophthalmitis after penetrating keratoplasty. Cornea 2005, 24:887–889.CrossRefPubMedGoogle Scholar
  46. 46.
    Stuart JC, Linn JG Jr: Candida albicans transmission by penetrating keratoplasty. Cornea 1984–1985, 3:285–287.Google Scholar
  47. 47.
    Sutphin JE, Pfaller MA, Hollis RJ, Wagoner MD: Donor-to-host transmission of Candida albicans after corneal transplantation. Am J Ophthalmol 2002, 134:120–121.CrossRefPubMedGoogle Scholar
  48. 48.
    Tappeiner C, Goldblum D, Zimmerli S, et al.: Donor-to-host transmission of Candida glabrata to both recipients of corneal transplants from the same donor. Cornea 2009, 28:228–230.CrossRefPubMedGoogle Scholar
  49. 49.
    Ison MG, Hager J, Blumberg E, et al.: Donor-derived disease transmission events in the United States: data reviewed by the OPTN/UNOS Disease Transmission Advisory Committee. Am J Transplant 2009, 9:1929–1935.CrossRefPubMedGoogle Scholar
  50. 50.
    Chittum ME, Grutzmacher RD, Oiland DM, Kalina RE: Contamination of corneal tissue from infected donors. Arch Opthalmol 1985, 103:802–804.Google Scholar
  51. 51.
    Hassan SS, Wilhelmus KR: Eye banking risk factors for fungal endophthalmitis compared with bacterial endophthalmitis after corneal transplantation. Am J Opthalmol 2005, 139(4):685–690.CrossRefGoogle Scholar
  52. 52.
    Karjalainen K, Vannas A: Bacterial contamination of donor corneas. Opthalmic Surg 1984, 15:770–772.Google Scholar
  53. 53.
    Wilhelmus KR, Hassan SS: The prognostic role of donor corneoscleral rim cultures in corneal transplantation. Opthalmology 2007, 114:440–445.CrossRefGoogle Scholar
  54. 54.
    Mattner F, Kola A, Fischer S, et al.: Impact of bacterial and fungal donor organ contamination in lung, heart-lung, heart and liver transplantation. Infection 2008, 36:207–212.CrossRefPubMedGoogle Scholar
  55. 55.
    Albano L, Bretagne S, Mamzer-Bruneel M, et al.: Evidence that graft-site candidiasis after kidney transplantation is acquired during organ recovery: a multicenter study in France. Clin Infect Dis 2009, 48:194–202.CrossRefPubMedGoogle Scholar
  56. 56.
    Calvino J, Romero R, Pintos E, et al.: Renal artery rupture secondary to pretransplantation Candida contamination of the graft in two different recipients. Am J Kidney Dis 1999, 33:E3.CrossRefPubMedGoogle Scholar
  57. 57.
    Laouad I, Buchler M, Noel C, et al.: Renal artery aneurysm secondary to Candida albicans in four kidney allograft recipients. Transplant Proc 2005, 37:2834–2836.CrossRefPubMedGoogle Scholar
  58. 58.
    Mai H, Champion L, Ouali N, et al.: Candida albicans arteritis transmitted by conservative liquid after renal transplantation: a report of four cases and review of the literature. Transplant 2006, 82:1163–1167.CrossRefGoogle Scholar
  59. 59.
    Spees EK, Light JA, Oakes DD, Reinmuth B: Experiences with cadaver renal allograft contamination before transplantation. Br J Surg 1982, 69:482–485.CrossRefPubMedGoogle Scholar
  60. 60.
    Canaud G, Timsit M, Zuber J, et al.: Early conservative intervention for candida contamination of preservative fluid without allograft nephrectomy. Nephrol Dial Transplant 2009, 24:1325–1327.CrossRefPubMedGoogle Scholar
  61. 61.
    Matignon M, Botterel F, Audard V, et al.: Outcome of renal transplantation in eight patients with Candida sp contamination of preservation fluid. Am J Transplant 2008, 8:697–700.CrossRefPubMedGoogle Scholar
  62. 62.
    Kuehnert MJ, Clark E, Lockhart SR, et al.: Candida albicans endocarditis associated with a contaminated aortic valve allograft: implications for regulation of allograft processing. Clin Infect Dis 1998, 27:688–691.CrossRefPubMedGoogle Scholar
  63. 63.
    Kanj SS, Welty-Wolf K, Madden J, et al.: Fungal infections in lung and heart-lung transplant recipients. Report of 9 cases and review of the literature. Medicine 1996, 75:142–156.CrossRefPubMedGoogle Scholar
  64. 64.
    Battaglia M, Dittono P, Fiore T, et al.: True mycotic arteritis by Candida albicans in 2 kidney transplant recipients from the same donor. J Urol 2000, 163:1236–1237.CrossRefPubMedGoogle Scholar
  65. 65.
    Ooi BS, Chen BT, Lim CH, et al.: Survival of a patient transplanted with a kidney infected with Cryptococcus neoformans. Transplant 1971, 11:428–429.CrossRefGoogle Scholar
  66. 66.
    Beyt BE Jr, Waltman SR: Cryptococcal endophthalmitis after corneal transplantation. N Engl J Med 1978, 298:825–826.CrossRefPubMedGoogle Scholar
  67. 67.
    de Castro LE, Sarraf OA, Lally JM, et al.: Cryptococcus albidus keratitis after corneal transplantation. Cornea 2005, 24:882–883.CrossRefPubMedGoogle Scholar
  68. 68.
    Keating MR, Guerrero MA, Daly RC, et al.: Transmission of invasive aspergillosis from a subclinically infected donor to three different organ transplant recipients. Chest 1996, 109:1119–1124.CrossRefPubMedGoogle Scholar
  69. 69.
    Tomazic J, Pirs M, Matos T, et al.: Multiple infections after commercial renal transplantation in India. Nephrol Dial Transplant 2007, 22:972–973.CrossRefPubMedGoogle Scholar
  70. 70.
    • Mueller NJ, Weisser M, Fehr T, et al.: Donor-derived aspergillosis from use of a solid organ recipient as a multiorgan donor. Transpl Infect Dis 2010, 12:54–59. This recent case report of donor-derived fungal disease transmission is reflective of the available published literature on specific transmission events. CrossRefPubMedGoogle Scholar
  71. 71.
    Garrido J, Lerma JL, Heras M, et al.: Pseudoaneurysm of the iliac artery secondary to Aspergillus infection in two recipients of kidney transplants from the same donor. Am J Kidney Dis 2003, 41:488–492.CrossRefPubMedGoogle Scholar
  72. 72.
    White JH: Fungal contamination of donor eyes. Br J Ophthalmol 1969, 53:30–33.CrossRefPubMedGoogle Scholar
  73. 73.
    Chkhotua A, Yussim A, Tovar A, et al.: Mucormycosis of the renal allograft: case report and review of the literature. Transpl Int 2001, 14:438–441.CrossRefPubMedGoogle Scholar
  74. 74.
    Mitwalli A, Malik GH, Al-Wakeel J, et al.: Mucormycosis of the graft in a renal transplant recipient. Nephrol Dial Transplant 1994, 9:718–720.PubMedGoogle Scholar
  75. 75.
    Alexander BD, Schell WA, Siston AM, et al.: Case report: Fatal Apophysomyces elegans infection transmitted by deceased donor renal grafts. Am J Transplant 2010 Aug 25 (Epub ahead of print).Google Scholar
  76. 76.
    Stas KJF, Louwagie PGLH, Van Damme BJC, et al.: Isolated zygomycosis in a bought living unrelated kidney transplant. Transpl Int 1996, 9:600–602.CrossRefPubMedGoogle Scholar
  77. 77.
    • Grossi PA, Fishman JA, AST Infectious Disease Community of Practice: Donor-derived infections in solid organ transplant recipients. Am J Transplant 2009, 9(Suppl 4):S19–S26. This article summarizes current donor screening practices and important considerations for future policy changes. CrossRefPubMedGoogle Scholar
  78. 78.
    • Fishman JA, Strong DM, Kuehnert MJ: Organ and tissue safety workshop 2007: advances and challenges. Cell Tissue Bank 2009, 10:271–280. This article summarizes proceedings from the Organ and Tissue Safety Workshop 2007, including the development of national reporting and tracking systems. CrossRefPubMedGoogle Scholar
  79. 79.
    Ison MG, Covington S: Ad Hoc Disease Transmission Advisory Committee: A Report to the UNOS Board. Richmond, Virginia; June 21–22, 2010.Google Scholar

Copyright information

© US Government 2010

Authors and Affiliations

  • Monika Roy
    • 1
  • Benjamin J. Park
    • 1
  • Tom M. Chiller
    • 1
  1. 1.Mycotic Diseases BranchCenters for Disease Control and PreventionAtlantaGAUSA

Personalised recommendations